For morethan25years, Teflon wasthemostcommonlyused materialforinjection laryngoplasty.However, theincidence of Teflon granuloma and the consequent deterioration of glotticfunction ultimately ledto the developmentof other injectable materials, and as a result, Teflon granulomas are no longer frequently encountered. We present a case of Teflon granuloma that was unusual in that (1) a long period of time had elapsed between the injection and the granulomaformation and (2) there was no changein the patient's glotticfunction.
Case report
A 4 1-year-old woman presented with a painless neck mass that had slowlyenlarged overthe previous 2 months. Her voice had remained unchanged. Her history was significant for a resection of a left vagal schwannoma 20 years earlier. Four months postoperatively, she underwent a procedure to improve her voice; this procedure included the injection of Teflon into the left vocal fold. She experienced an immediate improveme nt in glottic fun ction. However, 3 months after th e injection, she pr esented with a granuloma, altho ugh her voice was unchanged. She underwent successful local excision at that time . For almost 2 decades, she had no difficulty with swallowing , and she was pleased with her voice.
At this most recent presentation,physical examination revealed the presence of a firm, nontender, l-cm mass fixed to the left border of the cricoid cartilage. Noncontrast axial computed tomograp hy (CT) iden tified a variably hyperdense left-sided mass at th e level of th e cricothyroi d ligam ent an d the upper cricoid cartil age. An excisional biopsy revealed a firm ma ss fixed to the larynx at th e left edge of the cricothyroid membrane. Th is isprecisely the expected location ofthe lesion as the inflammatory mass expanded and followed the pat~of least resistance inferiorly through the loose tissue of the paraglottic space. The mass was excised, and pathologic evaluation of the excised mass was reported as islands of refractile foreign m aterial surrounded by inflammatory infiltrate and multinucleated giant cells.Posto peratively, th e patient's symp toms resolved.
Discussion
In the case ofvocal fold medialization th at is performed for vocal fold atrophy or scarr ing, the pre ferred technique is to inject hyaluronan or collagen into the medi al portion of the fold. I When medializing a malpositioned immobile fold, a bulk-forming material such as Teflon or hydroxyapatite is preferred. Prop er injection results in placement ofthe appropriate volume of material into a space bo rdered medi ally by the conus elasticus and later ally by the ala of th e thyroid cartila ge.
As describ ed by Tucker, th e procedure is performed under topical anesthesia.' The tip of the laryngoscope is used to lateralize the false vocal fold, and the needle is inserted into the superior sur face of th e vocal fold as far later ally and posteriorly as possible (figur e). The depth of injection should be such that th e injection volume is deposited just lateral to the thyroarytenoid muscl e so that the presence of the injected material results in medialization of the arytenoid cartilage . The volume of injection is determined by subj ectivevoice improvement as well as visualization of th e deficient vocal fold; typically,satisfactory results require avolumeofD.8to 1.2ml. Atrophy of the body of the vocal fold may be rem edied by a small supplemental injection mo re anteriorly. The final effect of this proc edure on glottic function cannot be assessed completely for at least 3 months.
Overinjection result s in extrusion, eith er through the needle hole immediately after injec tion or more slowly throu gh the inferior communication of th e paraglottic space with th e exter ior of th e larynx lateral to th e cricoth yroid membrane. Inappropriately deep placement of Teflon would result in the immediate appearance of a mass in this location, as described by Rubin.' Extralaryngeal migration ofTeflon particles isaknown risk after inj ection.Wassef et al reported a pati ent with a "teflonoma" th at mimicked a thyroid mass; the authors att ributed the formation of this lesion to a probable in-Volume 88, Number 1 jection across the thyro id capsule into the gland.' McCar thy et al describ ed a patient who was discovered to have a submucosal Teflon granuloma in the upper tr achea 4 years after inje ction ." Mittlema n and Marraccini also reported th ediscovery of Teflongranulomas in th e lun gs of a patient who had received periurethral injections for urinary incontinence, a find ing that raised serious concerns about the long-term safety of soft-tissue Teflon injection. ' These concerns contributed to the transition to other substances for injection laryngoplasty as the y became available.
Our pat ient pres ented with recurrent Teflongranulom a after 19asymptom atic years.The most striking aspect of this presentation is the absence of dysphonia. Varvares et al described two groups of patient s: tho se who did not have a good vocal result after injecti on and tho se who init ially had a good result but later develop ed dysphonia." The y concluded that th e first group likely had an improper injection, while the second group experienced granuloma form ation resulting in unfa vorable changes in vocal fold function. Our unusual case does not fall into either category, as th e patient's glottic functi on rem ain ed stabl e despite the partial escape of the Teflon from the paraglottic space. We conclude that although Teflon is no longer used for laryngoplasty, it should rem ain in the thoughts of clinicians .
